Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Moxifloxacin (0.3% w/v) Eye Ointment
Dosage Form : Eye Ointment
Packaging Type : Tube
Packaging : 5gm
Price : ₹1/-
Moxolunic Mini Eye Ointment contains Moxifloxacin 0.3% w/v, a broad-spectrum fluoroquinolone antibiotic eye ointment used for bacterial eye infections, including conjunctivitis, blepharitis, and superficial ocular infections.
It works by eliminating gram-positive and gram-negative pathogens, providing fast symptom relief and infection control.
Clinically, Moxolunic Mini Eye Ointment is recommended for night-time use or prolonged ocular contact, ensuring enhanced efficacy and patient compliance.
From a business perspective, Moxolunic Mini Eye Ointment strengthens the ophthalmic anti-infective segment, offering high prescription demand, repeat sales, and strong PCD pharma franchise potential at a best price for franchise partners.
Common side effects may include temporary blurred vision, mild stinging or burning sensation, redness, or eye irritation after application. Rarely, hypersensitivity reactions may occur.
Moxolunic Mini Eye Ointment is indicated for the treatment of bacterial conjunctivitis, keratitis, blepharitis, and other superficial ocular infections caused by susceptible Gram-positive and Gram-negative bacteria.
Use Moxolunic Mini Eye Ointment strictly under the guidance of an ophthalmologist. Avoid touching the tube tip to the eye or any surface to prevent contamination. Complete the full prescribed course even if symptoms improve. Discontinue use and consult a doctor if severe irritation or allergic reactions occur.
Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the tube tightly closed, and out of reach of children. Do not use beyond the expiry date.
Composition : Carboxymethylcellulose (1% w/v) + Oxychloro Complex (0.0075% w/v)
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation